TITAN PHARMACEUTICALS INC — Director's Dealing 2015

Aug 31, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP)
CIK: 0000910267
Period of Report: 2015-08-28

Reporting Person: Rubin Marc (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-28	Common Stock	P	50000	$0.715	Acquired	832200	Direct

Footnotes

F1: Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.71 to $0.72. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.